37: How to lead the fight against Brain Cancer with CEO of CNS Pharmaceuticals - John Climaco

In this episode I interviewed John Climaco, who is the CEO of CNS Pharmaceuticals. 

John is extremely passionate about innovation that makes people’s lives better. 

We discuss how his company’s new drug Berubicin is a game changer when it comes to fighting Brain Tumors.

For 15 years Mr. Climaco has served in leadership roles in a variety of healthcare companies. Recently Mr. Climaco served as the Executive Vice-President of Perma-Fix Medical S.A where he managed the development of a novel method to produce Technitium-99. 

Previously Mr. Climaco served as President and CEO of Axial Biotech, Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization

CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Some other things that we discuss on the podcast.

What makes their pharmaceutical innovation stand outWhy Glioblastoma is such a deadly diseaseTaking a project from idea to product to marketHow Cancer drugs work and why most of the conventional Cancer drugs don’t work for Brain cancer

Book recommendation

The Bold and the ColdHitlers first 100 days

Connect with John Climaco:-

https://cnspharma.comhttps://www.linkedin.com/in/john-climaco-62477a1/ https://www.linkedin.com/company/cnspharma/

If you enjoyed this episode then please subscribe, I will be interviewing other successful founders and investors to provide you a shortcut to success.

Follow instagram:- https://www.instagram.com/wantmoneygotmoney/

Hosted on Acast. See acast.com/privacy for more information.